Cargando…

Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a median lifespan of 2–3 years after diagnosis. There are few meaningful treatments that alter progression in this disease. Preclinical and clinical studies have demonstrated that neuroinflammation may play a key role in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gustafson, Michael P., Staff, Nathan P., Bornschlegl, Svetlana, Butler, Greg W., Maas, Mary L., Kazamel, Mohamed, Zubair, Adeel, Gastineau, Dennis A., Windebank, Anthony J., Dietz, Allan B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526569/ https://www.ncbi.nlm.nih.gov/pubmed/28742871 http://dx.doi.org/10.1371/journal.pone.0182002

Ejemplares similares

Ten-color, whole blood flow cytometric analysis of human myeloid subsets; implications for immune monitoring in cancer patients
por: Gustafson, Michael P, et al.
Publicado: (2013)

Comprehensive assessment of circulating immune cell populations in response to stereotactic body radiation therapy in patients with liver cancer
por: Gustafson, Michael P., et al.
Publicado: (2017)

Using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies
por: Gustafson, Michael, et al.
Publicado: (2015)

2219: Amyotrophic lateral sclerosis, stem cells and TALENted technology
por: Kurani, Shaheen, et al.
Publicado: (2018)

A systems biology approach to investigating the influence of exercise and fitness on the composition of leukocytes in peripheral blood
por: Gustafson, Michael P., et al.
Publicado: (2017)

A method for non-overlapping identification of human myeloid derived suppressor cells
por: Gustafson, Michael, et al.
Publicado: (2014)

Lymphoma monocyte crosstalk via HSP27 to promote immune suppression and chemotherapy resistance
por: Zhang, Zhe, et al.
Publicado: (2014)

Immune monitoring using the predictive power of immune profiles
por: Gustafson, Michael P, et al.
Publicado: (2013)

Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
por: Goyal, Namita A., et al.
Publicado: (2020)

Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors
por: Bornschlegl, Svetlana, et al.
Publicado: (2021)

Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis
por: Kwan, Thaddaeus, et al.
Publicado: (2020)

The Peripheral Immune System and Amyotrophic Lateral Sclerosis
por: McCombe, Pamela A., et al.
Publicado: (2020)

Smads as muscle biomarkers in amyotrophic lateral sclerosis
por: Si, Ying, et al.
Publicado: (2014)

Humoral immune activation in amyotrophic lateral sclerosis patients
por: Rentzos, Michael, et al.
Publicado: (2013)

Evaluation of Peripheral Immune Activation in Amyotrophic Lateral Sclerosis
por: Wang, Mengli, et al.
Publicado: (2021)

Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis
por: Schirò, Giuseppe, et al.
Publicado: (2022)

Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis
por: Calafatti, Matteo, et al.
Publicado: (2023)

Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses
por: Béland, Louis-Charles, et al.
Publicado: (2020)

A Method for Identification and Analysis of Non-Overlapping Myeloid Immunophenotypes in Humans
por: Gustafson, Michael P., et al.
Publicado: (2015)

Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients
por: Atanasova, Elena, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials
por: Khalid, Syed I., et al.
Publicado: (2017)

Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis
por: Liu, Zhouyang, et al.
Publicado: (2020)

Antiviral Immune Response as a Trigger of FUS Proteinopathy in Amyotrophic Lateral Sclerosis
por: Shelkovnikova, Tatyana A., et al.
Publicado: (2019)

Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
por: García-García, Raquel, et al.
Publicado: (2021)

Neuroimmune Crosstalk Between the Peripheral and the Central Immune System in Amyotrophic Lateral Sclerosis
por: Yu, Weiyi, et al.
Publicado: (2022)

288 Harnessing the potential of transcriptional adaptation as a mechanism for Amyotrophic lateral sclerosis
por: Gomez, Adriana Morales, et al.
Publicado: (2023)

Immunity Traits in Pigs: Substantial Genetic Variation and Limited Covariation
por: Flori, Laurence, et al.
Publicado: (2011)

Novel Insight Into the Role of Immune Dysregulation in Amyotrophic Lateral Sclerosis Based on Bioinformatic Analysis
por: Xie, Yongzhi, et al.
Publicado: (2021)

Tumor monocyte cross talk promotes lymphoma cell resistance to chemotherapy
por: Zhang, Zhe (Jenny), et al.
Publicado: (2013)

Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
por: Banerjee, Rebecca, et al.
Publicado: (2008)

The Potential Role of Cytotoxic Immune Effectors in Induction, Progression and Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)
por: Kaur, Kawaljit, et al.
Publicado: (2022)

Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study
por: Lee, Ikjae, et al.
Publicado: (2021)

Immune independent crosstalk between lymphoma and myeloid suppressor CD14(+)HLA-DR(low/neg) monocytes mediates chemotherapy resistance
por: Zhang, Zhe (Jenny), et al.
Publicado: (2015)

Amyotrophic lateral sclerosis: a clinical review
por: Masrori, P., et al.
Publicado: (2020)

Exercise and the immune system: taking steps to improve responses to cancer immunotherapy
por: Gustafson, Michael P, et al.
Publicado: (2021)

Expression profiling of suppressive monocytes (CD14+HLA-DRlow/neg) in cancer patients
por: Cordes, Stefan F, et al.
Publicado: (2013)

Amyotrophic lateral sclerosis and the innate immune system: protocol for establishing a biobank and statistical analysis plan
por: Kjældgaard, Anne-Lene, et al.
Publicado: (2020)

Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation
por: Katzeff, Jared S., et al.
Publicado: (2020)

Mechanisms of Immune Activation by c9orf72-Expansions in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Trageser, Kyle J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_26prv3ipk9rstgdien3dkdd8jf